GlaxoSmithKline revises colour and labelling of Relvar Ellipta inhaler GlaxoSmithKline is changing the colour of its Relvar Ellipta inhaler from blue to yellow after respiratory health professionals warned that patients could be confused.…
France, Germany, Belgium and Luxembourg suspend drug licences for some GVK Biosciences generics Four European countries have suspended the marketing authorisations for 25 generic medicines tested by GVK Biosciences at its plant in Hyderabad, India.…
An anthology of fun fights about science ‘I think you’ll find it’s a bit more complicated than that’ is a compilation of Ben Goldacre’s work from over the past 20 years.…
Q&A: Pharmacy regulation and the law Lawyer Noel Wardle, a partner at Charles Russell Speechlys, which specialises in business law, talks about UK pharmacy regulation and the threat of pharmacists facing prosecution for dispensing errors.…
Initial Fluad investigations find no manufacturing defectPreliminary investigations have found no manufacturing defect in the influenza vaccine Fluad, which has been linked to the deaths of 13 older people in Italy.…
McKesson cements acquisition of CelesioThe US healthcare services and information technology company McKesson Corporation has cemented its acquisition of German pharmaceutical wholesale and retail company Celesio AG.…
England’s Department of Health to review hospital pharmacy services to identify cost savings England’s Department of Health is to review hospital pharmacy services as part of a wider examination of how to cut waste in NHS procurement.…
Chief pharmacists warned of need for succession planning for procurement roles Succession planning is urgently needed to prepare for the swathe of experienced pharmacists buying medicines for hospitals who will shortly retire, an independent review has warned.…
Ibrutinib launched for treatment of mantle cell lymphoma and chronic lymphocytic leukaemia Ibrutinib, a Bruton’s tyrosine kinase inhibitor, has been launched in the UK for the treatment of mantle cell lymphoma or chronic lymphocytic leukaemia.…
Lundbeck’s chief executive resigns after code of ethics breachUlf Wiinberg has resigned as chief executive of the Danish pharmaceutical company Lundbeck after breaching the company’s code of ethics.…